Double minute chromosomes (DMs) are a hallmark of gene amplification. The relationship between the formation of DMs and the amplification of DM-carried genes remains to be clarified. The human colorectal cancer cell line NCI-H716 and human malignant primitive neuroectodermal tumor cell line SK-PN-DW are known to contain many DMs. To examine the amplification of DM-carried genes in tumor cells, we performed Affymetrix SNP Array 6.0 analyses and verified the regions of amplification in NCI-H716 and SK-PN-DW tumor cells. We identified the amplification regions and the DM-carried genes that were amplified and overexpressed in tumor cells. Using RNA interference, we downregulated seven DM-carried genes, (NDUFB9, MTSS1, NSMCE2, TRIB1, FAM84B, MYC and FGFR2) individually and then investigated the formation of DMs, the amplification of the DM-carried genes, DNA damage and the physiological function of these genes. We found that suppressing the expression of DM-carried genes led to a decrease in the number of DMs and reduced the amplification of the DM-carried genes through the micronuclei expulsion of DMs from the tumor cells. We further detected an increase in the number of cH2AX foci in the knockdown cells, which provides a strong link between DNA damage and the loss of DMs. In addition, the loss of DMs and the reduced amplification and expression of the DM-carried genes resulted in a decrease in cell proliferation and invasion ability.
The amplification of oncogenes plays an important role in the malignant transformation of human cells and is associated with tumor development and drug resistance. 1, 2 The mechanism of amplification leading to the overexpression of oncogenes varies between different types of cancers. 3, 4 Double minute chromosomes (DMs) are DNA segments containing amplified oncogenes in tumor cells. DMs are small, paired, acentric and autonomously replicating extrachromosomal structures composed of circular DNA a few Mb in size. 1, [5] [6] [7] [8] [9] DMs carrying amplified oncogenes are mostly present in solid tumors and neoplastic hematologic disorders. 10 The frequency of DMs carrying oncogenes appears higher than the frequency of homogeneously staining regions (HSRs) in tumors. 11 Previous reports showed that the elimination of DMs from tumor cells was greatly accelerated by treating cells with a low concentration of hydroxyurea (HU); this also led to the reduced amplification of the oncogene C-MYC and the reversion of the malignant phenotype of colorectal carcinoma COLO320DM cells and promyelocytic leukemia HL-60 cells. [12] [13] [14] Similar to this finding, the elimination of amplified multidrug resistance genes on DMs from human tumor cells using radiation therapy can reverse drug-resistance phenotypes. 15, 16 The elimination of DMs with reagents is mediated by the selective entrapment of DMs into cytoplasmic micronuclei (MN). In our study, these MN are designated as "DM-type MN." "Chromosome-type MN" are another type of MN and are formed either from acentric chromosomal fragments or from individual chromosomes. [17] [18] [19] The elimination of MN containing DMs and their amplified genes from tumor cells leads to a reversion of the tumor phenotype and cellular differentiation. 13, 20, 21 These findings reinforce the importance of DM-mediated gene amplification in tumorigenesis. Further studies of DMs, as well as the amplified genes that they carry, are important to cancer research.
Many human cancer cell lines are known to contain DMs. 15, 21, 22 However, the function of DMs and DM-carried genes in cancer cells remains to be clarified. In our molecular and cytogenetic study of cancer cells, we identified the amplification regions and the genes amplified and overexpressed via DMs. To clarify their function, we knocked down these genes using RNAi and then investigated the formation of DMs, the amplification of the DM-carried genes, and the physiological functions of these genes in cancer cells. We confirmed that suppression of the DM-carried amplified genes led to a decrease in the number of DMs and reduced the amplification levels of the DM-carried genes by MN expulsion of the DMs. We further found that gH2AX foci, a molecular marker for DNA damage, increased in the gene knockdown cells, which provides a strong link between DNA damage and the loss of DMs. In addition, the loss of DMs and the reduced amplification and expression of the DM-carried genes resulted in a reduction in cell proliferation and invasion ability.
Material and Methods

Cell line and cell culture
The human colorectal cancer cell line NCI-H716 and the human malignant primitive neuroectodermal tumor cell line SK-PN-DW were purchased from the American Type Culture Collection (ATCC, Manassas, VA) and were authenticated by the Beijing Microread Genetics (Beijing, China) using short tandem repeat (STR) analysis. NCI-H716 cells were routinely cultured in RPMI-1640 medium (Invitrogen, Auckland, New Zealand), and SK-PN-DW cells were cultured in DMEM medium (Invitrogen); both media were supplemented with 10% fetal bovine serum and grown at 37 C in 5% CO 2 .
Antibodies and reagents
Antibodies against c-MYC and NDUFB9 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). The anti-TRIB1 antibody and the anti-NSMCE2 antibody were purchased from Abnova (Taibei, Taiwan Quantitative reverse transcriptase-polymerase chain reaction and quantitative polymerase chain reaction
Total RNA was isolated using TRIzol reagent (Invitrogen), according to the manufacturer's protocol, and reverse transcribed into cDNA using the Transcriptor First Strand cDNA Synthesis Kit (Roche, Alameda, CA). DNA was routinely isolated from tumor cells and normal human peripheral blood. Polymerase chain reaction (PCR) analysis was performed on the cDNA and DNA using specific primers (Supporting Information Tables 1 and 2 ) under the following conditions: 94 C for 5 min; 45 cycles of 95 C for 5 sec, 60 C for 30 sec and 72 C for 30 sec; and 72 C for 7 min. The relative mRNA transcription and DNA amplification levels of each gene were normalized against ACTB mRNA and DNA levels, respectively.
Immunoblotting analysis
Cells were lysed for the immunoblotting analysis as described previously. 23 The lysates were separated using 12%
What's new? Double-minute chromosomes (DMs) are a hallmark of gene amplification and a major cytogenetic characteristic of malignant tumor cells. The function of DMs and DM-carried genes, however, remains to be clarified. Here, the authors identified amplification regions containing DM-carried genes that were themselves amplified and overexpressed in human malignant tumor cells. Knocking down the DM-carried amplified genes individually, they found that suppression of such oncogenes reduced the number of DMs, the amplification of these DM-carried genes, and cellular function. DNA damage and expulsion of micronuclei containing these DM-carried amplified genes may contribute to the decrease of DMs in tumor cells. SDS-PAGE and then transferred onto polyvinylidene difluoride membranes, followed by incubation with the primary antibodies then the fluorescent-conjugated secondary antibodies. The fluorescent signals were visualized using the Odyssey imaging system (Li-COR, Lincoln, NE).
Immunofluorescence analysis
Cells were seeded onto coverslips in six-well plates for 24 hr for the immunofluorescence analysis, as described previously, 24 and fixed with 4% paraformaldehyde. The coverslips were incubated with the anti-phospho-H2AX antibody, followed by the CF488 goat anti-mouse IgG secondary antibodies. DNA was visualized by counterstaining the cells with 4,6-diamidino-2-phenylindole (DAPI). Images were obtained using a Leica DM5000B microscope (Leica Microsystems, Solms, Germany). To analyze the extent of the DNA damage, the cells were grouped into four categories according to their gH2AX signals, including no signal, 0-30% signals, 30-60% signals and 60-100% signals using ImageJ (National Institutes of Health, Bethesda, MD) software. The Mann-Whitney Utest was performed using the Statistical Package for the Social Sciences (SPSS v19.0, International Business Machines Corporation, New York, NY) program to assess the significant difference between the different groups.
Preparation of metaphase spreads
The cells were harvested for metaphase spread preparation according to a previous study 10, 25 and were then stained with Giemsa. Approximately 100 karyotypes of each group were observed under the microscope, and the numbers of DMs were counted. A t-test was used to analyze the statistical difference in the number of DMs for each group, and the statistical significance was accepted when p < 0.05.
Fluorescence in situ hybridization analysis
The BAC clones were used as DNA probes and were labeled with Spectrum Cy3-dUTP or Green-dUTP. The probes were then hybridized to interphase and metaphase spreads of tumor cells as described previously. 26 Chromosomes were counterstained with DAPI. High-quality interphase and metaphase images were captured using a Leica DM5000 B fluorescence microscope and analyzed using the MetaMorph Imaging System (Universal Imaging, West Chester, PA).
Cell proliferation, cell cycle distribution and cell invasion assays
Cells were seeded in 96-well plates at 3 3 10 3 cells per well. CellTiter 96V R AQ UEOUS One Solution Cell Proliferation Assay (Promega, WI) was used to measure the cell viability during a 4-to 6-day time course according to the manufacturer's protocol. Three independent experiments were performed.
For the cell cycle distribution assay, the BD Cycletest TM Plus-DNA Reagent Kit (BD Biosciences, Bedford, MA) was used according to the manufacturer's protocol and as described previously. 27 The cells were harvested by trypsinization, washed in ice-cold PBS and then fixed using ice-cold 75% ethanol at 4 C for 24 hr. The cellular DNA was stained according to the manufacturer's protocol. Cell cycle distribution was analyzed using flow cytometry analysis (BioRad, Richmond, CA).
For the cell invasion assay, BD BioCoat TM Matrigel TM Invasion Chambers (BD Bioscience) were used according to the manufacturer's protocol and as described previously. 28 Briefly, the cells were incubated for 24 hr at 37 C and allowed to pass through the membrane. Afterward, the noninvading cells were removed from the upper surface of the membrane. The cells on the lower surface of the membrane were fixed with methanol and stained with hematoxylin and eosin, and the number of cells was counted. The chi-square test was performed to assess the statistical difference in the invasion rates, and statistical significance was accepted when p < 0.05.
Results
Identification of genes amplified via DMs
DMs represent the tumorigenesis manifestation of protooncogene amplification. 22 To acquire the molecular characteristics of genes amplified in tumor cells, we performed an Affymetrix SNP Array 6.0 analyses to verify the amplification regions in human colorectal cancer NCI-H716 cells. (Fig. 1a) . There are 15 genes (DEPDC6, COL14A1, MRPL13, NDUFB9, MTSS1, ZNF572, SQLE, KIAA0196, NSMCE2, TRIB1, FAM84B, POU5F1B, MYC, FGFR2 and ATE1) located in these four amplified regions (Fig. 1a) . As overexpression of the genes is effective for their function in tumor cells, we performed quantitative reverse transcriptase-PCR (qRT-PCR) analysis to determine whether these genes were overexpressed when compared with normal colon tissue (Fig. 1b) . The results showed that ten genes, NDUFB9, MTSS1, ZNF572, SOLE, KIAA0196, NSMCE2, TRIB1, FAM84B and MYC, located on 8q24.13 and 8q24.21 and FGFR2 located on 10q26.13 were at least 2-fold overexpressed in the cancer cells compared to the normal colon tissue (Fig. 1b) . Subsequently, we performed quantitative PCR (qPCR) analysis to determine whether these genes were amplified in NCI-H716 cells. The results showed that all of the overexpressed genes, NDUFB9, MTSS1, ZNF572, SOLE, KIAA0196, NSMCE2, TRIB1, FAM84B, MYC and FGFR2, were amplified by at least 2-fold in the cancer cells when compared to the normal human peripheral blood DNA (Fig. 1c) . Therefore, we found ten genes that are amplified and overexpressed in NCI-H716 cells.
Amplified genes might exist on DMs and/or at HSRs in cancer cells. 29 To ascertain whether the amplified genes were located on DMs, fluorescence in situ hybridization (FISH) analysis was performed. Six BAC clones specifically covering the ten amplified genes (NDUFB9, MTSS1, ZNF572, SOLE, KIAA0196, NSMCE2, TRIB1, FAM84B, MYC and FGFR2) were selected as FISH probes and hybridized to metaphase spreads of NCI-H716 cells. The results showed that these six BACs all hybridized to DMs in the NCI-H716 cells (Fig. 1d) . This result suggests that DMs carry these amplified genes in NCI-H716 cells.
Similarly, we also examined the high amplification areas and the amplified genes in the DM-containing SK-PN-DW tumor cells using Affymetrix SNP Array 6.0 analysis and qPCR analysis (data not shown). We identified that MYC was also amplified via DMs in SK-PN-DW tumor cells (Supporting Information Fig. 1A ).
The production of DMs is abolished in DM-carried-gene knockdown cells, resulting in the reduced amplification of DM-carried genes
Amplified genes play critical roles in tumor cells. 29 To further address the role of the amplified genes contained in the DMs of tumor cells, we selected gene-silencing siRNAs to target seven of the above DM-carried genes (Supporting Information Table 3 ); we also generated pSuper-short hairpin RNA (shRNA) expression vectors to knock down the expression of these genes. Immunoblotting and qRT-PCR analyses showed that the expression of NDUFB9, MTSS1, NSMCE2, TRIB1, FAM84B, MYC and FGFR2 decreased in stable NCI-H716 shRNA cells (Supporting Information Figs. 2A-2G) , and the expression of MYC also decreased in stable SK-PN-DW shRNA cells (Supporting Information Fig. 1B) .
We next examined whether knockdown of these amplified genes affected the production of DMs. We performed a DM counting assay on the karyotypes of each NCI-H716 shRNA cell. Interestingly, we found that the number of DMs was significantly decreased in the knockdown cells when compared to the vector control cells (Figs. 2a-2f) . We also confirmed this result in the SK-PN-DW knockdown cells (Supporting Information Fig. 1C) . Furthermore, in the sh-FAM84B NCI-H716 cells, we found no DMs in 16.5% of the karyotypes, but we observed a large number of very small, sediment-like DMs in 65.2% of the karyotypes (Fig. 2g) . These results indicate that knockdown of the amplified genes induced genomic instability and abolished DMs formation in the tumor cells.
Next, we performed qPCR analysis on the DM-abolished cells to determine whether the amplification levels of the DM-carried genes were also affected. In each shRNA NCI-H716 cell line, we analyzed the amplification levels of NDUFB9, MTSS1, NSMCE2, TRIB1, FAM84B, MYC and FGFR2 (Figs. 3a-3g) . The results showed that almost all of the DM-carried genes had reduced amplification in these NCI-H716 shRNA cells compared to the control cells, with the exception of the increased amplification of the NDUFB9 gene in sh-NDUFB9 cells (Figs. 3a-3g) . These results suggest that along with the loss of DMs, the amplification levels of the DM-carried genes decreased; the exception to this might be a result of an adaptation of a particular gene under suppression conditions.
MN carrying DMs fragments are induced following knocking down of DM-carried genes
Because the number of DMs and the amplification levels of DM-carried genes decreased, we examined the fate of these DMs prior to being lost from the cells. We performed FISH analysis to detect the amplification and location of DMs in the interphase of each knockdown cell line using Cy3-or greenlabeled BAC clones containing the DM-carried genes. We found obvious induction of MN in the NCI-H716 shRNA cells. The MN could be divided into two FISH results: positive MN (MN1) stained with both DAPI and Cy3, and negative MN (MN2) stained with DAPI only (Supporting Information  Fig. 3) . We counted the cells that produced MN, and the results are summarized in Table 1 . We found the number of stably knockdown cells carrying MN with and without BAC signals increased; moreover, the percentage of cells that had MN1 greatly increased (Table 1) . We further confirmed this result in SK-PN-DW knockdown cells (Supporting Information Table 4 ). These results imply that DMs participating in MN1 are lost from cancer cells. The induction of MN1 is consistent with the above results concerning the decrease in the number of DMs and the amplification level of the carried genes. We speculate that the formation of MN1 may be associated with the loss of DMs.
Suppression of the DM-carried genes caused DNA damage in tumor cells
Low concentrations of HU have been found to cause DNA damage, detectable as gH2AX foci, in cells. 12 We wanted to determine whether the suppression of the DM-carried genes could cause DNA damage in addition to the observed DM loss. We performed immunofluorescence analysis to detect the amount of gH2AX foci in three knockdown NCI-H716 cell lines. We grouped cells into four categories based on the amount of signals in each cell (Fig. 4a) . The Mann-Whitney U-test was used to assess the significant differences in the gH2AX signals in the knockdown and control cells. A corrected p value less than 0.003 was considered significant. From the analysis, we found more cells with gH2AX foci in the NCI-H716 shRNA knockdown cells than the control cells. This was consistent with the immunoblot analysis of gH2AX expression (Fig. 4b) . We further confirmed this result in SK-PN-DW knockdown cells, and using the Mann-Whitney U-test, a corrected p value less than 0.005 was considered statistically significant (Supporting Information Fig.  1D ). The results indicate that suppression of the DM-carried genes is effective in inducing gH2AX foci formation in these cells. This suggests that the knocking down of the DM-carried genes can result in genomic instability, as well as DNA damage, and can lead to the loss of DMs from tumor cells.
Suppression of the DM-carried genes reduced malignant behavior
The amplification of DM-carried genes plays important roles in tumor cells; therefore, we evaluated the effect of the suppression of the DM-carried genes, as well as the loss of DMs, on the physiological functions of the cells. We examined the cell growth rate of three knockdown NCI-H716 cell lines. We found that cell proliferation was impaired in each cell line when compared to the control cell line (Fig. 5a) . Knocking down the three amplified genes induced a notable increase in the percentage of cells in G1 phase (Fig. 5b ). These results demonstrate that the expression of the DM-carried amplified genes is essential for the physiological function of tumor cells.
The ability of the cells to invade and migrate to the periphery of normal tissue is an important characteristic of tumor cells. To further examine the invasion of cells stably transfected with shRNA, we performed a basement membrane invasion assay after 24 hr of subculture. All three knockdown cell lines showed a significant decrease in cell invasion compared to the control cell line (Fig. 5c , Supporting Information Table 5 ). The results demonstrate that the DM-carried genes in tumor cells contribute to the cell's invasive characteristics.
Discussion
DMs are cytogenetic hallmarks of extra-chromosome genomic amplification, and many DMs are found in the malignant tumor cells. 22 Our study focused on the function of DMs and gene amplification in malignant tumor cells. Using the Affymetrix SNP Array 6.0 analyses, we identified the regions of high amplification and the amplified genes located in these regions. We then tested the mRNA transcription and verified the DNA amplification of these genes. DMs are a major cytogenetic characteristic of malignant tumor cells; thus, we investigated the location of these amplified genes and identified the genes that were amplified via DMs.
To test the role of these DM-mediated amplified and overexpressed genes in malignant tumor cells, we used an RNAi system to knock down the expression of these genes. We generated sh-NDUFB9, sh-MTSS1, sh-NSMCE2, sh-TRIB1, sh-FAM84B, sh-MYC, and sh-FGFR2 stable knockdown NCI-H716 and SK-PN-DW cell lines using the pSuper-shRNA system. Amazingly, when the DM-carried genes were suppressed, the number of DMs declined in each knockdown cell line compared to the control cell line. In the sh-FAM84B knockdown cells, in particular, we did not detect DMs in 16.5% of the cells, but there were many very small DMs in 65.2% cells. These results indicate that the suppression of DM-carried genes led to genomic instability. Gene amplification is a significant event in these cell lines, so we investigated the amplification levels of the DM-carried genes in these knockdown cells. As the number of DMs decreased, the amplification levels of most DM-carried genes also decreased in these gene knockdown cells compared to the control cells.
As described previously, elimination of the amplified genes was accelerated by treating cells with a low dose of HU, and the elimination was accompanied by the specific inclusion of DMs into MN. 12, 30 The elimination of DMs into MN can also be induced by a broad range of DNA replication inhibitors used at low doses, as well as low-dose radiation therapy. 15, 30 We were very interested in whether DMs would gather into MN when the expression of the DMcarried genes was suppressed. To trace the DMs and the DM-carried genes in the knockdown cells, we performed FISH analysis using BAC clones containing the DM-carried genes as probes to detect MN formation. We designated the positive signals as MN1 (DM-type MN), which may mediate the elimination of the DMs. We designated the negative signals as MN2 (chromosome-type MN); this type arises from a centric whole chromosome that was bound by microtubules from both spindle poles. This type of MN has no DMs and thus would have no signal due to the lack of hybridization of the DM-specific probes.
DMs incorporate into MN, which leads to the elimination of the DMs from the cell through extrusion. Both MN with or without signals were increased in the shRNA stably transfected cells compared to the control cells. The percentage of MN1 increased in the shRNA cells, which suggests that the DMs are in the MN expelled from the cells. We observed the aggregation of DM-carried genes in interphase, illustrating the subsequent extrusion from the nucleus and the formation of MN that will be expelled from the cell. As previously reported, a plasmid was first multimerized to form a large circular molecule that resembles a DM and was then integrated into the chromosome, forming HSR. 31, 32 However, in our study, we did not detect HSR in the metaphase nucleus. These results indicate that knocking down the DM-carried genes leads to the incorporation of DMs into MN, resulting in DM elimination from the cells and reduced amplification of the DM-carried genes. In addition, reducing the amplification of the DM-carried genes consequently causes a decline in DM formation.
A previous study showed that low-dose HU could induce gH2AX foci throughout the nucleus during S-phase. 12 It is reasonable to assume that HU induced gH2AX foci not only on chromosome arms but also in DMs. 12 Unexpectedly, DNA damage in DMs and in chromosomes has different consequences. The cell cycle will be arrested to restore damaged DNA in chromosomes, but DMs heavily stained with gH2AX signals always aggregated at metaphase, and they remained behind when the chromatids separated during anaphase, thus generating MN. We have performed immunofluorescence to determine the amount of gH2AX foci in the knockdown cells. We grouped cells into four categories based on the amount of gH2AX foci present in the knockdown cells using immunofluorescence, and we found that knockdown cells showed an increased amount of gH2AX foci compared to control, which is consistent with the immunoblot results.
We speculated that suppression of the DM-carried genes is effective at inducing gH2AX foci formation, which is a sensitive DNA damage marker. The underlying cause might be that deficiency of the genes that are implicated in tumorigenesis would lead to genomic instability and DNA recombination. 33 DNA damage is highly cytotoxic and is associated with genomic instability. These results indicate that gH2AX foci increased in the gene knockdown cells, which provides a strong link between DNA damage and the loss of DM. Knocking down DM-carried genes can cause DNA damage and can lead to DM loss from tumor cells through the extrusion of MN.
Elimination of DM-amplified genes from tumor cells via MN leads to a reversion in tumor phenotype and cellular differentiation. 20, 21 We examined the physiological functions of the shRNA cells. We found that knocking down of all the DM-carried genes led to a marked decrease in cell proliferation ability and cell invasion ability. The decrease in the number of DMs and in the amplification levels of the DMcarried genes in malignant tumor cells might result in cell cycle arrest and reduction of the cell invasion ability. Using the DM-containing human malignant tumor cell lines as models, we conclude that the formation of DMs is associated with the amplification and expression of the DM-carried genes.
